• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Cannabinoid Medicine Company Names Former Abbott Exec as CEO


August 03, 2016

Biotica Pharmaceuticals Inc. (St. Petersburg, FL) has elected Abbott and Bayer veteran Dr. P.C. Sundareswaran as its President & CEO.

The company reports that Sundareswaran's "expertise in growing and scaling businesses, developing winning strategies, operations, marketing, sales and innovation for global businesses and broad brand portfolios" will will lead Biotica in discovering, developing, and commercializing cannabinoid-based medicines for neuropathic pain, cancer, Alzheimer's, Parkinson's Disease and esophagitis.

Related Videos